Investor profile
Thairm Bio has backed 4 European tech companies across 7 funding rounds between 2020 and 2026, joining rounds totalling €74M. Most active in Healthtech. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| EnteroBiotix | UK | 2 | €40M |
| Phlo | UK | 2 | €22M |
| Pneumagen | UK | 2 | €9.1M |
| Microplate Dx | UK | 1 | €2.9M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| EnteroBiotix | Other | €22M | 2026-05 |
| EnteroBiotix | Series A | €18M | 2021-09 |
| Phlo | Series A | €11M | 2023-02 |
| Phlo |
| €11M |
| 2024-04 |
| Pneumagen | Other | €4.6M | 2022-01 |
| Pneumagen | Early VC | €4.5M | 2020-05 |
| Microplate Dx | Other | €2.9M | 2023-09 |
